“I do not take the market’s view as gospel truth, but I also do not assume it is foolish or stupid”

ASK Group’s Bharat Shah on why the market is his guidepost when it comes to deciphering tangible price and intangible value

N Mahalakshmi - October 17, 2020

Chitale Group’s success comes from a healthy mix of technology and tradition

Having crossed ₹12 billion in topline, the 80-year-old Pune group is planning to enter the big league 

Anishaa Kumar - September 17, 2020

What’s happening at Coforge is more than just a name change

CEO Sudhir Singh believes his new team and an aggressive incentive structure could soon take the company to the billion-dollar mark 

V Keshavdev - September 30, 2020

Malaki, VEEN and EvocusH2O are redefining the meaning of bottled water

From gold flakes to black alkaline water, these premium bottled water brands go beyond simply quenching your thirst

Shailaja Mohapatra - September 15, 2020

Building a future-ready, innovative healthcare industry

India’s scientific excellence provides us the opportunity to achieve self-reliance in pharmaceuticals, biopharma and holistic care

Kiran Mazumdar-Shaw - August 28, 2020

Tata Elxsi is steering away from the automotive lane to remain on the growth track

The overshadowed Tata company is proving its worth with swift and smart detours 

Meenakshi Radhakrishnan-Swami - July 30, 2020

Why Ashish Kacholia, Mukul Agrawal and Kedaara Capital are hot on Religare Enterprises

Despite its troubled past, its healthcare insurance business may turn out to be a dark horse 

Anishaa Kumar - July 16, 2020

Is there more upside in store for pharma stocks?

Over the past year, the Nifty Pharma Index has gained 23% while the Nifty has declined by 11% 

June 30, 2020